Ligand Pharmaceuticals
LGND
#4390
Rank
C$2.60 B
Marketcap
$142.43
Share price
1.28%
Change (1 day)
67.86%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.12

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.13. In 2022 the company made an earnings per share (EPS) of -$2.69 a decrease over its 2021 EPS that were of $4.69.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.12-178.8%
2022-$2.69-157.23%
2021$4.69-2571.43%
2020-$0.19-100.46%
2019$41.52353.48%
2018$9.161025%
2017$0.81-700%
2016-$0.14-100.87%
2015$15.681859.32%
2014$0.805.36%
2013$0.768.0704505322479E+18%
2012$0.0000000000-100%
2011$0.66-194.23%
2010-$0.71548.38%
2009-$0.11-98.7%
2008-$8.38-136.52%
2007$22.95-787.8%
2006-$3.34-14.58%
2005-$3.91-21.31%
2004-$4.96-55.15%
2003-$11.0781.33%
2002-$6.102.74%
2001-$5.94-45.93%
2000-$10.99-14.56%
1999-$12.86-45.52%
1998-$23.60-3.97%
1997-$24.58132.31%
1996-$10.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$19.19 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.49-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.75 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.47 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.52 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.36 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.38 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.94 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.11 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA